April 11, 2022 -- BostonGene will present six poster presentations at the American Association for Cancer Research (AACR) Annual Meeting held April 8-13 in New Orleans. The presentations will highlight BostonGene’s advancement of novel analytical tools and technologies developed to enhance detection and diagnosis in cancer patients.
The following three presentations are scheduled for April 11 from 9 a.m. to 12:30 p.m.
- Poster 1216 "Combinatory technologies for single sample gene expression projection onto a cohort sequenced with a different technology for personalized clinical decision-making"
- Poster 1227 "Molecular-based tumor grade predictor for breast cancer, clear cell renal cell carcinoma, and lung adenocarcinoma"
- Poster 2061 "Deep immune profiling by mass cytometry revealed an association between the state of immune system before treatment and response to checkpoint inhibitor therapy in clear cell renal cell carcinoma"
The remaining three posters will be presented as e-posters. BostonGene will exhibit at booth #3641.
Copyright © 2022 scienceboard.net